Erlotiniblet) and leukopenia Patient Reports February 11, 2012

Erlotiniblet) Side Effects Report #5404265-9
Erlotiniblet) side effect was reported by a Health Professional from UNITED STATES on July 16, 2007. Female patient, 71 years of age, weighting 181.0 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotiniblet). After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, diarrhoea, leukopenia, mucosal inflammation, neutrophil count decreased, protein total decreased, pyrexia. Erlotiniblet) dosage: 100 MG. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.